Back to search

Article

Prevention of neointimal hyperplasia after coronary artery bypass graft via local delivery of sirolimus and rosuvastatin: network pharmacology and in vivo validation

2023-10-09

Abstract excerpt

<h4>Background: </h4> Coronary artery bypass graft (CABG) is generally used to treat complex coronary artery disease. Treatment success is affected by neointimal hyperplasia (NIH) of graft and anastomotic sites. Although sirolimus and rosuvastatin individually inhibit NIH progression, the efficacy of combination treatment remains unknown. Methods We identified cross-targets associated with CABG, sirolimus, and ro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b0da3ef0-077d-5da9-bd5e-f012583cc292
DOI
10.21203/rs.3.rs-3344075/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prevention of neointimal hyperplasia after coronary artery bypass graft via local delivery of sirolimus and rosuvastatin: network pharmacology and in vivo validationDOI 10.21203/rs.3.rs-3344075/v1
Select a neighboring publication to make it the new centre.